135 related articles for article (PubMed ID: 30381896)
1. A novel antibody combination to identify KIR2DS2
Blunt MD; Rettman P; Bastidas-Legarda LY; Fulton R; Capizzuto V; Naiyer MM; Traherne JA; Khakoo SI
HLA; 2019 Jan; 93(1):32-35. PubMed ID: 30381896
[TBL] [Abstract][Full Text] [Related]
2. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
3. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
[TBL] [Abstract][Full Text] [Related]
4. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors.
Warren HS; Campbell AJ; Waldron JC; Lanier LL
Int Immunol; 2001 Aug; 13(8):1043-52. PubMed ID: 11470774
[TBL] [Abstract][Full Text] [Related]
5. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
[TBL] [Abstract][Full Text] [Related]
6. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
[TBL] [Abstract][Full Text] [Related]
7. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
[TBL] [Abstract][Full Text] [Related]
8. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
[TBL] [Abstract][Full Text] [Related]
9. Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
Romagné F; André P; Spee P; Zahn S; Anfossi N; Gauthier L; Capanni M; Ruggeri L; Benson DM; Blaser BW; Della Chiesa M; Moretta A; Vivier E; Caligiuri MA; Velardi A; Wagtmann N
Blood; 2009 Sep; 114(13):2667-77. PubMed ID: 19553639
[TBL] [Abstract][Full Text] [Related]
10. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
Cassidy S; Mukherjee S; Myint TM; Mbiribindi B; North H; Traherne J; Mulder A; Claas FH; Purbhoo MA; Das J; Khakoo SI
Eur J Immunol; 2015 Feb; 45(2):492-500. PubMed ID: 25359276
[TBL] [Abstract][Full Text] [Related]
11. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2.
Vitale M; Carlomagno S; Falco M; Pende D; Romeo E; Rivera P; Della Chiesa M; Mavilio D; Moretta A
Int Immunol; 2004 Oct; 16(10):1459-66. PubMed ID: 15314042
[TBL] [Abstract][Full Text] [Related]
13. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
[TBL] [Abstract][Full Text] [Related]
14. NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Gras Navarro A; Kmiecik J; Leiss L; Zelkowski M; Engelsen A; Bruserud Ø; Zimmer J; Enger PØ; Chekenya M
J Immunol; 2014 Dec; 193(12):6192-206. PubMed ID: 25381437
[TBL] [Abstract][Full Text] [Related]
15. The Activating Human NK Cell Receptor KIR2DS2 Recognizes a β
Thiruchelvam-Kyle L; Hoelsbrekken SE; Saether PC; Bjørnsen EG; Pende D; Fossum S; Daws MR; Dissen E
J Immunol; 2017 Apr; 198(7):2556-2567. PubMed ID: 28202613
[TBL] [Abstract][Full Text] [Related]
16. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
Askar M; Avery R; Corey R; Lopez R; Thomas D; Pidwell D; Eghtesad B; Miller C; Fung J; Zein NN
Liver Transpl; 2009 Nov; 15(11):1557-63. PubMed ID: 19877200
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
18. [Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].
Gao XN; Lin J; Wang LL; Gao L; Jin HJ; Sun JF; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):656-60. PubMed ID: 19549382
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
20. Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.
Ramírez-De los Santos S; Sánchez-Hernández PE; Muñoz-Valle JF; Palafox-Sánchez CA; Rosales-Rivera LY; García-Iglesias T; Daneri-Navarro A; Ramírez-Dueñas MG
Dis Markers; 2012; 33(4):201-6. PubMed ID: 22960345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
